不仅仅是一个意外:一个胰岛素瘤病例
Asanka B Ekanayake1,2, Harrison Stubbs1, Dominique Broutin3
1Internal Medicine, HCA Florida Osceola Hospital, Kissimmee, USA.
Cureus
|December 11, 2023
概括
本案例研究突出了一个罕见的胰岛素瘤诊断在一个非糖尿病患者呈现复发性低血糖和惠普尔三位一体. 早期检测对于管理这种罕见的疾病及其相关症状至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 胰岛素瘤是一种罕见的胰腺瘤,在非糖尿病患者中引起低血糖症.
- 诊断依赖于惠普尔的三位一体:低血糖,神经糖症状和葡萄糖缓解.
- 复发性低血糖症需要彻底调查,以排除内源性原因.
研究的目的:
- 在37岁的女性中呈现胰岛素瘤的病例,患有复发性低血糖症.
- 强调非糖尿病患者胰岛素瘤的诊断方法.
- 为了强调惠普尔三位数在诊断胰岛素瘤中的重要性.
主要方法:
- 临床表现:发作,复发性低血糖 (血糖<50毫克/分升),惠普尔三位一体.
- 诊断试验:排除其他原因,禁食72小时,测量胰岛素,C-,β-甲酸.
- 图像:腹部MRI以定位胰腺质量.
主要成果:
- 患者表现出惠普尔三位一体,葡萄糖水平低至32 mg/dL.
- 72小时的禁食显示了胰岛素和C-的升高,并抑制了β-hydroxybutyrate.
- 腹部MRI证实1.3厘米的胰腺尾部质量,与胰岛素瘤一致.
结论:
- 对于患有低血糖和惠普尔三位一体的非糖尿病患者来说,专注的诊断方法至关重要.
- 早期发现胰岛素瘤可以及时治疗并预防并发症.
- 这一案例强调了胰岛素瘤的诊断挑战,常常呈现异常.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
179
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
179
Insulin: Biosynthesis, Chemistry, and Preparation
387
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
387
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Hypoglycemia and Glucagon
266
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
266
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K


